King & Spalding LLP’s Frankfurt team focuses on the pharmaceutical, medical device, biotechnology, healthcare and food sectors. Ulf Grundmann leads the practice, advising on cross-border litigation, regulatory compliance, misleading advertising, and competitor disputes, with particular expertise in parallel import mandates.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Key clients
- Novartis
- CSL Behring GmbH (Germany)
- Olin Germany Upstream GmbH & Co. KG
- GSK GlaxoSmithKline Consumer Healthcare (a Haleon Company)
- Teva Pharmaceuticals Europe B.V.
- ratiopharm GmbH
- Teva Deutschland GmbH
- Dr. Willmar Schwabe GmbH & Co.KG
- biomo Group
- Roche Diagnostics GmbH
- Deutsche Homöopathie-Union DHU-Arzneimittel GmbH & Co. KG (DHU)
- Eckes-Granini
Work highlights
Represented Novartis Pharma AG in a case against Danish parallel importer Abacus regarding parallel trade and repackaging of pharmaceutical products.
Representing CSL Behring in disputes over IP rights following the CJEU rulings of November 2022.
Representing Teva Pharmaceuticals in protecting trade marks and IP rights against parallel importers, in the context of the Falsified Medicines Directive.
Practice head
Ulf Grundmann